| Symbol | CTKB |
|---|---|
| Name | CYTEK BIOSCIENCES, INC. |
| Sector | INDUSTRIALS |
| Region | North America |
| Industry | Biotechnology: Laboratory Analytical Instruments |
| Address | 47215 LAKEVIEW BOULEVARD, FREMONT, California, 94538, United States |
| Telephone | +1 877 922-9835 |
| Fax | — |
| — | |
| Website | https://www.cytekbio.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001831915 |
| Description | Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Additional info from NASDAQ: |
(99% Neutral) CYTEK BIOSCIENCES, INC. (CTKB) Provides Update on claims for Cytek’s Favor on Three of Four Asserted Claims
Read moreJury Finds in Cytek’s Favor on Three of Four Asserted Claims; Company to Challenge Remaining Finding
Read moreJiang Wenbin 🟡 adjusted position in 36.3K shares (4 derivative) of Cytek Biosciences, Inc. (CTKB) at $4.67 Transaction Date: Aug 18, 2026 | Filing ID: 000006
Read moreMcCombe William D. 🟡 adjusted position in 11.9K shares (3 derivative) of Cytek Biosciences, Inc. (CTKB) at $4.67 Transaction Date: Aug 18, 2026 | Filing ID: 000004
Read moreMUIR GLENN P 🟡 adjusted position in 0 shares (1 derivative) of Cytek Biosciences, Inc. (CTKB) Transaction Date: Aug 18, 2026 | Filing ID: 000007
Read moreHolder Michael 🟡 adjusted position in 0 shares (1 derivative) of Cytek Biosciences, Inc. (CTKB) Transaction Date: Aug 18, 2026 | Filing ID: 000005
Read moreChin Richard 🟡 adjusted position in 0 shares (1 derivative) of Cytek Biosciences, Inc. (CTKB) Transaction Date: Aug 18, 2026 | Filing ID: 000005
Read moreYan Ming 🟡 adjusted position in 8.1K shares (4 derivative) of Cytek Biosciences, Inc. (CTKB) at $4.67 Transaction Date: Aug 18, 2026 | Filing ID: 000009
Read moreFeuchtwang Ilan 🟢 acquired 368.5K shares (2 derivative) of Cytek Biosciences, Inc. (CTKB) at $4.66 Transaction Date: Aug 10, 2026 | Filing ID: 000002
Read moreCytek Biosciences to Report Second Quarter 2026 Financial Results on August 5, 2026
Read more